Fusion DNA Inc.
Fusion DNA Inc. is a Vancouver-based pre-revenue company building a bio-inspired VOC sensing platform that fuses genetically engineered receptor proteins with microelectrode arrays and machine learning to digitize scent signatures for healthcare, agriculture, defense, and other verticals.
- Company typePrivate
- Founded-
- HeadquartersVancouver, Canada
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
What Fusion DNA Inc. does
Fusion DNA Inc. is a privately held, pre-revenue biotechnology company headquartered in Vancouver, British Columbia, developing a bio-inspired platform for digitizing volatile organic compound (VOC) signatures. The company's core technology fuses molecular biology with electrophysiology: genetically engineered microorganisms express receptor proteins that are purified, immobilized onto microelectrode arrays, and exposed to target VOCs, producing distinct parallel electrical response patterns that reflect the chemical composition of an environment. These analog signals are processed, digitized via ADCs, and interpreted through machine learning models compared against reference scent profiles.
The platform is positioned as a versatile sensing architecture applicable across six verticals: healthcare (the primary segment, focused on non-invasive breath, skin, and wound emission monitoring for diagnostics and patient monitoring), agriculture (precision crop stress and pest detection), food safety (freshness and contamination monitoring), forensics (decomposition VOC detection), military and defense (chemical, explosive, and human presence detection), and search and rescue (locating trapped or buried individuals).
The business model is sales-led and not yet commercialized. Go-to-market relies on strategic collaborations and pilot programs targeting enterprise customers, with contemplated revenue streams including hardware biosensor sales, software licenses, and subscription-based data services once prototypes mature. The company discloses no funding rounds, customers, pricing, management team, patents, or formal partnerships in the available source material, consistent with its development-stage status.
Fusion DNA Inc. firmographics
Firmographics- Name
- Fusion DNA Inc.
- Legal name
- Fusion DNA Inc.
- Website
- https://fusiondna.ca
- Company type
- Private
- Operating status
- Operating
- Short description
- Fusion DNA Inc. is a Vancouver-based pre-revenue company building a bio-inspired VOC sensing platform that fuses genetically engineered receptor proteins with microelectrode arrays and machine learning to digitize scent signatures for healthcare, agriculture, defense, and other verticals.
- Ownership category
- akta.pro rank
Where Fusion DNA Inc. is headquartered
LocationHeadquarters
- HQ city
- Vancouver
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
Fusion DNA Inc. business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations
Revenue model
- VOC Sensing Platform: Development-stage company offering a next-generation VOC sensing platform. Revenue streams likely include hardware biosensor sales, software licenses, and potentially subscription-based data services. The platform architecture enables tailoring to specific sectors (healthcare, agriculture, defense, food safety) with customizable form factors.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Fusion DNA Inc. product offering
Product offeringCore offering
Fusion DNA Inc. develops a bio-inspired volatile organic compound (VOC) sensing platform that mimics biological olfactory systems. The platform genetically engineers receptor proteins, immobilizes them on microelectrode arrays, and uses signal processing and machine learning to convert scent into digital signals. It targets sectors including healthcare, agriculture, food safety, forensics, defense, and search and rescue.
Product overview
Fusion DNA Inc. offers a unified VOC sensing platform consisting of bio-inspired sensors and detection systems. The core platform combines molecular biology with electrophysiology, using genetically engineered microorganisms that express specific receptor proteins. These receptors are purified, immobilized on sensor surfaces, and interfaced with microelectrode arrays to create electronic nose (e-nose) biosensors. The platform converts scent to digital signals through a multi-step process: receptor-based detection generates chemical signatures, which are analyzed and converted to electrical signals, then digitized and interpreted using machine learning algorithms against known scent profiles. The platform targets multiple sectors including healthcare, agriculture, search and rescue, defense, and food safety.
Differentiator
Problem solved
Functional benefit
Products and services
- VOC Sensing Platform
Companies that use Fusion DNA Inc.
Customer profileSegments6 records
Ideal customer profiles5 records
Fusion DNA Inc. technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature4 records
Fusion DNA Inc. partnerships and signals
Strategic signalScale indicators1 record
Recent moves4 records
Expansion highlights4 records
Fusion DNA Inc. competitors and assessment
Company assessmentDirect peers
- Sensigent: US-based electronic nose company (formerly Cyranose/Sentelligence) using neural-network pattern recognition across multi-sensor arrays for food, agriculture, medical and environmental sensing. Closely aligned architecture (sensor array + ML interpretation) and target verticals.
- Aryballe: French digital olfaction company building bio-inspired electronic noses combining biochemical receptor arrays with optics/electronics. Same core architecture (biology + electronics, multi-receptor pattern recognition) and same multi-industry GTM (automotive, food, consumer, healthcare).
- Owlstone Medical: Cambridge-based biotech developing breath-based VOC diagnostic platforms (FAIMS sensor + disease VOC signatures). Directly comparable to Fusion DNA's healthcare-primary VOC sensing thesis and bio-derived receptor approach.
- Alpha MOS (AMETEK MOCON): Established electronic nose systems provider (Heracles, eNose) serving food, beverage, packaging and environmental monitoring. Closest commercial-stage direct competitor with overlapping sensor-platform and multi-sector use cases (food safety, agriculture, environmental).
- AerNos: Nano-enabled multi-gas sensor startup targeting health, environmental monitoring and smart-cities applications with miniaturized CMOS-compatible gas sensor chips. Compares on miniaturized form factor drive and multi-vertical commercial ambition.
Emerging players
- Plair: Swiss startup using laser-based spectrometry (Rapid-E) for real-time bioaerosol and pollen detection. Comparable on real-time, field-deployable VOC/bio-detection ambition in environmental monitoring and ambient intelligence verticals.
Broad incumbents
- ams OSRAM (sensor division): Austrian-listed broad sensor and photonics conglomerate with VOC/gas-sensing product lines as part of a much larger portfolio. Indirect competition and potential acquisition/acquirer — relevant for both strategic benchmarking and exit optionality.
- Sensirion: Swiss-listed manufacturer of high-volume gas, humidity and flow sensors for automotive, HVAC, medical and consumer electronics. Does not specialize in bio-inspired receptors but represents the incumbent scale player that any emergent VOC sensor must compete against on cost and reliability.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights5 records
Customer concentration
Fusion DNA Inc. financial estimates
Financial estimateRevenue estimate
Valuation estimate
Fusion DNA Inc. leadership team
Management profileNumber of profiles
Fusion DNA Inc. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Fusion DNA Inc. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Fusion DNA Inc.
What does Fusion DNA Inc. do?
Fusion DNA Inc. develops a bio-inspired volatile organic compound (VOC) sensing platform that mimics biological olfactory systems. The platform genetically engineers receptor proteins, immobilizes them on microelectrode arrays, and uses signal processing and machine learning to convert scent into digital signals. It targets sectors including healthcare, agriculture, food safety, forensics, defense, and search and rescue.
Is Fusion DNA Inc. a public or private company?
Fusion DNA Inc. is a private company. It is classified as unknown and is currently operating.
When was Fusion DNA Inc. founded?
Fusion DNA Inc. was founded in -1.
Where is Fusion DNA Inc. based?
Fusion DNA Inc. is headquartered in Vancouver, Canada, in the North America region.
How does Fusion DNA Inc. make money?
One revenue line is on record: VOC Sensing Platform.
Who are Fusion DNA Inc.'s main competitors?
Direct peers on record are Sensigent, Aryballe, Owlstone Medical, Alpha MOS (AMETEK MOCON) and AerNos. Plair is listed as an emerging player. Broad incumbents are ams OSRAM (sensor division) and Sensirion.
Does Fusion DNA Inc. have an API?
No public API is recorded for Fusion DNA Inc..